Clinicopathologic findings and braf mutation in cutaneous melanoma in young adults

Applied Immunohistochemistry and Molecular Morphology

Volumn 22, Issue 1, 2014, Pages 57-64

  Estrozi, Bruna ^a,b   MacHado, Juliana ^a   Rodriguez, Rubens ^c   Bacchi, Carlos E ^a,b  

^a Consultoria em Patologia ^*  (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Instituto de Patologia   (Brazil)

Author keywords

BRAF; melanoma; molecular biology; mutation; skin; young adults

Indexed keywords

B RAF KINASE;

ADULT; ARTICLE; BLEEDING; CANCER PATIENT; CUTANEOUS MELANOMA; ELASTOSIS; FAMILY HISTORY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; INFLAMMATORY INFILTRATE; LEG; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MELANOCYTIC NEVUS; MELANOMA; MOLECULAR BIOLOGY; PERINEURAL INVASION; PRIORITY JOURNAL; SKIN CARCINOGENESIS; THICKNESS; TRUNK; ULCER; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MELANOMA; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84891705821     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PDM.0b013e318298c1d9     Document Type: Article

References (59)

1. Purdue MP, Freeman LE, Anderson WF, et al. Recent trends in incidence of cutaneous melanoma among US Caucasian young adults. J Invest Dermatol. 2008;128:2905-2908.
2. Boddie AW Jr, Smith JL Jr, McBride CM. Malignant melanoma in children and young adults: effect of diagnostic criteria on staging and end results. South Med J. 1978;71:1074-1078. (Pubitemid 9042559)
3. Wu SJ, Lambert DR. Melanoma in children and adolescents. Pediatr Dermatol. 1997;14:87-92. (Pubitemid 27193833)
4. Borbola K, Banfalvi T, Fejos Z, et al. Etiologic factors of malignant melanoma in young adults. Orv Hetil. 2005;146:1481-1487. (Pubitemid 46118681)
5. Bleyer A, Viny A, Barr R. Cancer in 15-to 29-year-olds by primary site. Oncologist. 2006;11:590-601. (Pubitemid 43967614)
6. Ceballos PI, Ruiz-Maldonado R, Mihm MC Jr. Melanoma in children. N Engl J Med. 1995;332:656-662.
7. Sander B, Karlsson P, Rosdahl I, et al. Cutaneous malignant melanoma in Swedish children and teenagers 1973-1992: a clinicopathological study of 130 cases. Int J Cancer. 1999;80:646-651. (Pubitemid 29066271)
8. Saenz NC, Saenz-Badillos J, Busam K, et al. Childhood melanoma survival. Cancer. 1999;85:750-754. (Pubitemid 29075297)
9. Ferrari A, Bono A, Baldi M, et al. Does melanoma behave differently in younger children than in adults A retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics. 2005;115:649-654. (Pubitemid 43373024)
10. Livestro DP, Kaine EM, Michaelson JS, et al. Melanoma in the young: differences and similarities with adult melanoma: a casematched controlled analysis. Cancer. 2007;110:614-624. (Pubitemid 47106151)
11. Moore-Olufemi S, Herzog C, Warneke C, et al. Outcomes in pediatric melanoma: comparing prepubertal to adolescent pediatric patients. Ann Surg. 2011;253:1211-1215.
12. Govindarajan B, Bai X, Cohen C, et al. Malignant transformation of melanocytes to melanoma by constitutive activation of mitogenactivated protein kinase kinase (MAPKK) signaling. J Biol Chem. 2003;278:9790-9795. (Pubitemid 36800479)
13. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949-954. (Pubitemid 34716871)
14. Homsi J, Kashani-Sabet M, Messina JL, et al. Cutaneous melanoma: prognostic factors. Cancer Control. 2005;12:223-229. (Pubitemid 41552313)
15. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257-2317. (Pubitemid 38072572)
16. Alston RD, Rowan S, Eden TO, et al. Cancer incidence patterns by region and socioeconomic deprivation in teenagers and young adults in England. Br J Cancer. 2007;96:1760-1766. (Pubitemid 46847212)
17. Marrett LD, Frood J, Nishri D, et al. Cancer incidence in young adults in Canada: preliminary results of a cancer surveillance project. Chronic Dis Can. 2002;23:58-64. (Pubitemid 34650783)
18. de Sa BC, Rezze GG, Scramim AP, et al. Cutaneous melanoma in childhood and adolescence: retrospective study of 32 patients. Melanoma Res. 2004;14:487-492. (Pubitemid 40221139)
19. Pratt CB, Palmer MK, Thatcher N, et al. Malignant melanoma in children and adolescents. Cancer. 1981;47:392-397. (Pubitemid 11179339)
20. Weir HK, Marrett LD, Cokkinides V, et al. Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006. J Am Acad Dermatol. 2011;65(5 Suppl 1):S38-S49.
21. Mackie RM, Watt D, Doherty V, et al. Malignant melanoma occurring in those aged under 30 in the west of Scotland 1979-1986: a study of incidence, clinical features, pathological features and survival. Br J Dermatol. 1991;124:560-564.
22. Jemal A, Saraiya M, Patel P, et al. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. J Am Acad Dermatol. 2011;65(S17-25):e11-e13.
23. Firoz EF, Warycha M, Zakrzewski J, et al. Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma. Clin Cancer Res. 2009;15:2573-2580.
24. Robinson JK, Rigel DS, Amonette RA. Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996. J Am Acad Dermatol. 1997;37:179-186. (Pubitemid 27355701)
25. Reed KB, Brewer JD, Lohse CM, et al. Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota. Mayo Clin Proc. 2012;87:328-334.
26. Ting W, Schultz K, Cac NN, et al. Tanning bed exposure increases the risk of malignant melanoma. Int J Dermatol. 2007;46:1253-1257.
27. Scalzo DA, Hida CA, Toth G, et al. Childhood melanoma: a clinicopathological study of 22 cases. Melanoma Res. 1997;7:63-68. (Pubitemid 27110284)
28. Schmid-Wendtner MH, Berking C, Baumert J, et al. Cutaneous melanoma in childhood and adolescence: an analysis of 36 patients. J Am Acad Dermatol. 2002;46:874-879.
29. Whiteman DC, Valery P, McWhirter W, et al. Risk factors for childhood melanoma in Queensland, Australia. Int J Cancer. 1997;70:26-31. (Pubitemid 27059701)
30. Lefkowitz A, Schwartz RA, Janniger CK. Melanoma precursors in children. Cutis. 1999;63:321-324.
31. Silverberg NB. Update on malignant melanoma in children. Cutis. 2001;67:393-396. (Pubitemid 33756283)
32. Pappo AS. Melanoma in children and adolescents. Eur J Cancer. 2003;39:2651-2661. (Pubitemid 37468306)
33. Berg P, Wennberg AM, Tuominen R, et al. Germline CDKN2A mutations are rare in child and adolescent cutaneous melanoma. Melanoma Res. 2004;14:251-255. (Pubitemid 39159136)
34. Paradela S, Fernandez-Torres R, Fonseca E. Controversial issues in congenital nevi. Actas Dermosifiliogr. 2009;100:548-561.
35. Rhodes AR, Wood WC, Sober AJ, et al. Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus. Plast Reconstr Surg. 1981;67:782-790. (Pubitemid 11126407)
36. Kaplan EN. The risk of malignancy in large congenital nevi. Plast Reconstr Surg. 1974;53:421-428.
37. Bittencourt FV, Marghoob AA, Kopf AW, et al. Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis. Pediatrics. 2000;106:736-741.
38. Davidoff AM, Cirrincione C, Seigler HF. Malignant melanoma in children. Ann Surg Oncol. 1994;1:278-282.
39. Spatz A, Ruiter D, Hardmeier T, et al. Melanoma in childhood: an EORTC-MCG multicenter study on the clinico-pathological aspects. Int J Cancer. 1996;68:317-324. (Pubitemid 26384134)
40. Paradela S, Fonseca E, Pita-Fernandez S, et al. Melanoma under 18 years and pregnancy: report of three cases. Eur J Dermatol. 2010;20:186-188.
41. Mehregan AH, Mehregan DA. Malignant melanoma in childhood. Cancer. 1993;71:4096-4103. (Pubitemid 23172998)
42. Tamir G, Milo Y, Rothem A, et al. Cutaneous malignant melanoma in young adults under age 30. Isr J Med Sci. 1996;32:1290-1296. (Pubitemid 27042460)
43. Rao BN, Hayes FA, Pratt CB, et al. Malignant melanoma in children: its management and prognosis. J Pediatr Surg. 1990;25: 198-203. (Pubitemid 20046188)
44. Platz A, Egyhazi S, Ringborg U, et al. Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site. Mol Oncol. 2008;1:395-405.
45. Lee JH, Choi JW, Kim YS. Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis. Br J Dermatol. 2011;164: 776-784.
46. Pollock PM, Harper UL, Hansen KS, et al. High frequency of BRAF mutations in nevi. Nat Genet. 2003;33:19-20. (Pubitemid 36068675)
47. Dong J, Phelps RG, Qiao R, et al. BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma. Cancer Res. 2003;63:3883-3885. (Pubitemid 36917898)
48. Uribe P, WistubaII, Gonzalez S. BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin. Am J Dermatopathol. 2003;25:365-370. (Pubitemid 37169463)
49. Omholt K, Platz A, Kanter L, et al. NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression. Clin Cancer Res. 2003;9:6483-6488. (Pubitemid 38031837)
50. Yazdi AS, Palmedo G, Flaig MJ, et al. Mutations of the BRAF gene in benign and malignant melanocytic lesions. J Invest Dermatol. 2003;121:1160-1162. (Pubitemid 37430987)
51. Maldonado JL, Fridlyand J, Patel H, et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst. 2003;95: 1878-1890.
52. Shinozaki M, Fujimoto A, Morton DL, et al. Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas. Clin Cancer Res. 2004;10:1753-1757. (Pubitemid 38435567)
53. Sasaki Y, Niu C, Makino R, et al. BRAF point mutations in primary melanoma show different prevalences by subtype. J Invest Dermatol. 2004;123:177-183. (Pubitemid 38833479)
54. Colombino M, Capone M, Lissia A, et al. BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma. J Clin Oncol. 2012;30:2522-2529.
55. Kumar R, Angelini S, Snellman E, et al. BRAF mutations are common somatic events in melanocytic nevi. J Invest Dermatol. 2004;122:342-348. (Pubitemid 38281054)
56. Greene VR, Johnson MM, Grimm EA, et al. Frequencies of NRAS and BRAF mutations increase from the radial to the vertical growth phase in cutaneous melanoma. J Invest Dermatol. 2009;129:1483-1488.
57. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353:2135-2147. (Pubitemid 41653105)
58. Bulliard JL. Site-specific risk of cutaneous malignant melanoma and pattern of sun exposure in New Zealand. Int J Cancer. 2000;85:627-632.
59. Holman CD, Armstrong BK, Heenan PJ. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst. 1986;76:403-414. (Pubitemid 16119774)